View in EDS PDF Full Text

Impact of Diabetes on the Efficacy of Low-Voltage Area Ablation for Persistent Atrial Fibrillation: A Subanalysis of the SUPPRESS-AF Trial.

Saved in:
Bibliographic Details
Title: Impact of Diabetes on the Efficacy of Low-Voltage Area Ablation for Persistent Atrial Fibrillation: A Subanalysis of the SUPPRESS-AF Trial.
Authors: Ozaki T; Cardiovascular Division National Hospital Organization Osaka National Hospital Osaka Japan., Inoue K; Cardiovascular Division National Hospital Organization Osaka National Hospital Osaka Japan., Mishima T; Cardiovascular Division National Hospital Organization Osaka National Hospital Osaka Japan., Ohashi T; Cardiovascular Division National Hospital Organization Osaka National Hospital Osaka Japan., Osaki S; Cardiovascular Division National Hospital Organization Osaka National Hospital Osaka Japan., Ueda Y; Cardiovascular Division National Hospital Organization Osaka National Hospital Osaka Japan., Masuda M; Cardiovascular Center Kansai Rosai Hospital Amagasaki Japan., Sunaga A; Department of Cardiovascular Medicine Osaka University Graduate School of Medicine Suita Japan., Tanaka N; Cardiovascular Center Sakurabashi Watanabe Advanced Healthcare Hospital Osaka Japan., Watanabe T; Department of Cardiovascular Medicine Yao Municipal Hospital Yao Japan., Minamiguchi H; Cardiovascular Division, Osaka International Medical and Science Center Osaka Keisatsu Hospital Osaka Japan., Egami Y; Division of Cardiology Osaka Rosai Hospital Sakai Japan., Oka T; Department of Cardiovascular Medicine Osaka University Graduate School of Medicine Suita Japan., Minamisaka T; Department of Cardiovascular Medicine Yao Municipal Hospital Yao Japan., Kanda T; Cardiovascular Center Kansai Rosai Hospital Amagasaki Japan., Okada M; Cardiovascular Center Sakurabashi Watanabe Advanced Healthcare Hospital Osaka Japan., Kawasaki M; Division of Cardiology Osaka General Medical Center Osaka Japan., Matsuda Y; Cardiovascular Center Kansai Rosai Hospital Amagasaki Japan., Tanaka K; Cardiovascular Center Sakurabashi Watanabe Advanced Healthcare Hospital Osaka Japan., Makino N; Cardiovascular Division, Osaka International Medical and Science Center Osaka Keisatsu Hospital Osaka Japan., Kida H; Department of Cardiovascular Medicine Osaka University Graduate School of Medicine Suita Japan., Hikoso S; Cardiovascular Medicine Nara Medical University Kashihara Japan., Dohi T; Department of Cardiovascular Medicine Osaka University Graduate School of Medicine Suita Japan., Sotomi Y; Department of Cardiovascular Medicine Osaka University Graduate School of Medicine Suita Japan., Sakata Y; Department of Cardiovascular Medicine Osaka University Graduate School of Medicine Suita Japan.
Corporate Authors: OCVC‐SUPPRESS‐AF investigators *
Source: Journal of the American Heart Association [J Am Heart Assoc] 2026 Jun 16; Vol. 15 (12), pp. e047450. Date of Electronic Publication: 2026 Jun 15.
Publication Type: Journal Article; Randomized Controlled Trial; Multicenter Study; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101580524 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2047-9980 (Electronic) Linking ISSN: 20479980 NLM ISO Abbreviation: J Am Heart Assoc Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2047-9980
DOI:10.1161/JAHA.125.047450